RhumbLine Advisers
ACET icon

RhumbLine Advisers’s Adicet Bio ACET Stock Holding History

RhumbLine Advisers’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,301
Closed -$25.2K – 4194
2024
Q2 		$25.2K Sell
1,301
-2,480
-66% -$66.5K ﹤0.01% 3828
2024
Q1 		$142K Buy
3,781
+836
+28% +$34.6K ﹤0.01% 3325
2023
Q4 		$89K Buy
2,945
+41
+1% +$894 ﹤0.01% 3487
2023
Q3 		$63.6K Sell
2,904
-35
-1% -$1.24K ﹤0.01% 3591
2023
Q2 		$114K Sell
2,939
-37
-1% -$3.27K ﹤0.01% 3469
2023
Q1 		$274K Buy
2,976
+140
+5% +$17.6K ﹤0.01% 2643
2022
Q4 		$406K Buy
2,836
+163
+6% +$40.7K ﹤0.01% 2561
2022
Q3 		$608K Buy
2,673
+173
+7% +$43.9K ﹤0.01% 2406
2022
Q2 		$584K Buy
2,500
+520
+26% +$114K ﹤0.01% 2410
2022
Q1 		$633K Buy
1,980
+573
+41% +$132K ﹤0.01% 2312
2021
Q4 		$394K Buy
1,407
+106
+8% +$18.2K ﹤0.01% 2604
2021
Q3 		$163K Buy
1,301
+35
+3% +$4.34K ﹤0.01% 2940
2021
Q2 		$208K Buy
+1,266
New +$258K ﹤0.01% 2916
2020
Q2 		– Sell
-176
Closed -$20K – 3056
2020
Q1 		$20K Hold
176
– – ﹤0.01% 2904
2019
Q4 		$29K Buy
176
+2
+1% +$1.01K ﹤0.01% 2932
2019
Q3 		$172K Buy
174
+19
+12% +$21.2K ﹤0.01% 2783
2019
Q2 		$177K Buy
155
+65
+72% +$58.9K ﹤0.01% 2825
2019
Q1 		$69K Buy
+90
New +$81.8K ﹤0.01% 2899

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

RhumbLine Advisers's ACET Position: Q3 2024 in Review

RhumbLine Advisers sold out of Adicet Bio (ACET) in Q3 2024, closing a stake of 1,301 shares — an estimated $25.2K sold.

RhumbLine Advisers first reported a position in ACET in Q1 2019 and held it in 18 quarters. The position peaked at $633K in Q1 2022. 64 funds tracked by Wall St. Rank hold ACET as of Q3 2024.

  • RhumbLine Advisers reported no remaining Adicet Bio position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 1,301 Adicet Bio shares in Q3 2024, an estimated $25.2K.
  • RhumbLine Advisers first reported a position in Adicet Bio in Q1 2019 and held it in 18 quarters.
  • RhumbLine Advisers's Adicet Bio position peaked at $633K in Q1 2022.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.